Literature DB >> 26966626

Cochlear Implantation in Neurobrucellosis.

Münir Demir Bajin1, Özden Savaş2, Filiz Aslan3, Levent Sennaroğlu1.   

Abstract

BACKGROUND: Neurobrucellosis is a disease consisting of a wide spectrum of complications such as peripheral neuropathy, cranial nerve involvement, ataxia, meningeal irritation, paraplegia, seizures, coma, and even death. The vestibulocochlear nerve seems to be the most commonly affected cranial nerve (10%). We present a patient with neurobrucellosis whose auditory perception and speech intelligibility skill performances improved after cochlear implantation. CASE REPORT: A 35 year-old woman was admitted to another hospital 2 years ago with the symptoms of headache, nausea, and altered consciousness, who was finally diagnosed with neurobrucellosis. She developed bilateral profound sensorineural hearing loss during the following 6 months. There was no benefit of using hearing aids. After successful treatment of her illness, she was found to be suitable for cochlear implantation. After the operation, her auditory perception skills improved significantly with a Categories of Auditory Performance (CAP) score of 5. According to clinical observations and her family members' statements, her Speech Intelligibility Rating (SIR) score was 3. Her speech intelligibility skills are still improving.
CONCLUSION: Our case report represents the second case of hearing rehabilitation with cochlear implantation after neurobrucellosis. Cochlear implantation is a cost-effective and time-proven successful intervention in post-lingual adult patients with sensorineural hearing loss. Early timing of the surgery after appropriate treatment of meningitis helps the patient to achieve better postoperative results.

Entities:  

Keywords:  Cochlear implantation; neurobrucellosis; sensorineural hearing loss

Year:  2016        PMID: 26966626      PMCID: PMC4767300          DOI: 10.5152/balkanmedj.2015.15544

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  9 in total

1.  Hearing status in brucellosis.

Authors:  Yildirim A Bayazit; Mustafa Namiduru; Nurhayat Bayazit; Enver Ozer; Muzaffer Kanlikama
Journal:  Otolaryngol Head Neck Surg       Date:  2002-07       Impact factor: 3.497

2.  Investigation of hearing loss in patients with acute brucellosis by standard and high-frequency audiometry.

Authors:  T Ozturk Kaygusuz; I Kaygusuz; S S Kilic; S Yalcin; S Felek
Journal:  Clin Microbiol Infect       Date:  2005-07       Impact factor: 8.067

3.  Cochlear implantation in older adults.

Authors:  Frank R Lin; Wade W Chien; Lingsheng Li; Danisa M Clarrett; John K Niparko; Howard W Francis
Journal:  Medicine (Baltimore)       Date:  2012-09       Impact factor: 1.889

4.  Relationship of hearing impairment to dementia and cognitive dysfunction in older adults.

Authors:  R F Uhlmann; E B Larson; T S Rees; T D Koepsell; L G Duckert
Journal:  JAMA       Date:  1989-04-07       Impact factor: 56.272

5.  Cross-modal plasticity and speech perception in pre- and postlingually deaf cochlear implant users.

Authors:  Kristi A Buckley; Emily A Tobey
Journal:  Ear Hear       Date:  2011-02       Impact factor: 3.570

Review 6.  Cochlear implantation in adults: a systematic review and meta-analysis.

Authors:  James M Gaylor; Gowri Raman; Mei Chung; Jounghee Lee; Madhumathi Rao; Joseph Lau; Dennis S Poe
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2013-03       Impact factor: 6.223

7.  Neurobrucellosis: clinical and diagnostic features.

Authors:  Tumer Guven; Kenan Ugurlu; Onder Ergonul; Aysel Kocagul Celikbas; Sebnem Eren Gok; Selcuk Comoglu; Nurcan Baykam; Basak Dokuzoguz
Journal:  Clin Infect Dis       Date:  2013-02-27       Impact factor: 9.079

8.  Cochlear implantation in neurobrucellosis.

Authors:  E Alpin Guneri; Gunay Kirkim; Bulent M Serbetcioglu; Taner K Erdag; Ataman Guneri
Journal:  Otol Neurotol       Date:  2009-09       Impact factor: 2.311

Review 9.  Overview of neurobrucellosis: a pooled analysis of 187 cases.

Authors:  Hanefi Cem Gul; Hakan Erdem; Semai Bek
Journal:  Int J Infect Dis       Date:  2009-05-09       Impact factor: 3.623

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.